🇺🇸 FDA
Patent

US 6541483

Acridone-derived compounds useful as antineoplastic and antiretroviral agents

expired A61PA61P31/00A61P31/12

Quick answer

US patent 6541483 (Acridone-derived compounds useful as antineoplastic and antiretroviral agents) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P31/00, A61P31/12, A61P31/18, A61P35/00